AstraZeneca expands anti-infectives portfolio with up to $505 million buy of France’s Novexel and makes deal with Forest; MedImmune recall, motavizumab update
Article | 24 December 2009
Anglo-Swedish drug major AstraZeneca revealed yesterday afternoon that it is to acquire Novexel, a French speciality pharmaceutical company focused on ...
Enjoying this article? To continue reading you need to login or subscribe.